Short interfering RNA directed against the E2F-1 gene suppressing gastric cancer progression in vitro

Oncology Reports

Volumn 21, Issue 5, 2009, Pages 1345-1353

  Xie, Yubo ^a   Yin, Yongshuo ^a   Li, Lei ^a   Ma, Yulin ^a   Xiao, Qiang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

E2F 1; Gastric cancer; MGC 803 cells; Small interfering RNA

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STOMACH CARCINOMA;

APOPTOSIS; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE PROGRESSION; E2F1 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; HUMANS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 67649336794     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000360     Document Type: Article

References (29)

1. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20, 2006.
2. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
3. Bartek J, Bartkova J and Lukas J: The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 8: 805-814, 1996.
4. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
5. Sherr CJ: The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60: 3689-3695, 2000.
6. Johnson DG, Cress WD, Jakoi L and Nevins JR: Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci USA 91: 12823-12827, 1994.
7. Suzuki T, Yasui W, Yokozaki H, Naka K, Ishikawa T and Tahara E: Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer 81: 535-538, 1999.
8. Rabbani F, Richon VM, Orlow I, et al: Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 91: 874-881, 1999.
9. Muller H and Helin K: The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 1470: M1-M12, 2000.
10. Zhang SY, Liu SC, Johnson DG and Klein-Szanto AJ: E2F-1 Gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res 60: 5972-5976, 2000.
11. Zamore PD: RNA interference: listening to the sound of silence. Nat Struct Biol 8: 746-750, 2001.
12. Hammond SM, Bernstein E, Beach D and Hannon GJ: An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404: 293-296, 2000.
13. Cunningham D, Jost LM, Purkalne G and Oliveira J: ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of gastric cancer. Ann Oncol 16 (Suppl. 1): i22-i23, 2005.
14. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ and Kay MA: RNA interference in adult mice. Nature 418: 38-39, 2002.
15. Wilda M, Fuchs U, Wossmann W and Borkhardt A: Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21: 5716-5724, 2002.
16. Cerutti H: RNA interference: traveling in the cell and gaining functions? Trends Genet 19: 39-46, 2003.
17. Dykxhoorn DM, Novina CD and Sharp PA: Killing the messenger: short RNAs that silence gene expression. Nature Rev Mol Cell Biol 4: 457-467, 2003.
18. Coumoul X, Li W, Wang RH and Deng C: Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res 32: 85, 2004.
19. Nevins JR: The Rb/E2F pathway and cancer. Hum Mol Genet 10: 699-703, 2001.
20. Johnson DG, Schwarz JK, Cress WD and Nevins JR: Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352, 1993.
21. Fan J and Bertino JR: Functional roles of E2F in cell cycle regulation. Oncogene 14: 1191-1200, 1997.
22. Wu CL, Classon M, Dyson N and Harlow E: Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol Cell Biol 16: 3698-3706, 1996.
23. Ishizaki J, Nevins JR and Sullenger BA: Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat Med 2: 1386-1389, 1996.
24. Field SJ, Tsai FY, Kuo F, et al: E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561, 1996.
25. Irwin M, Marin MC, Phillips AC, et al: Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407: 645-648, 2000.
26. Furukawa Y, Sutheesophon K, Wada T, Nishimura M, Saito Y, Ishii H and Furukawa Y: Apaf-1 is a mediator of E2F-1-induced apoptosis. J Biol Chem 277: 39760-39768, 2002.
27. Silvia M, Rolf M and Roland EK: Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2F. Oncogene 22: 4943-4952, 2003.
28. Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jaattela M, Bartek J and Lukas J: E2F activity is essential for survival of Myc-overexpressing human cancer cells. Oncogene 21: 6498-6509, 2002.
29. Xiao Q, Li L, Xie Y, et al: Transcription factor E2F-1 is upregulated in human gastric cancer tissues and its overexpression suppresses gastric tumor cell proliferation. Cell Oncol 4: 335-349, 2007.